JPRN-UMIN000052314招募中Unknown
Development of Novel Immunotherapy for Cancer - Development of Novel Immunotherapy for Cancer
Ehime University Graduate School of Medicine0 个研究点目标入组 20 人开始时间: 2023年10月1日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Other
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Donors whose Hb values are less than 9.0 g/dL.
研究者
相似试验
已完成
1 期
Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal CancerFallopian Tube CancerPeritoneal CancerOvarian CancerNCT01416038ImmunoVaccine Technologies, Inc. (IMV Inc.)19
招募中
不适用
Development of new approaches for immunotherapy of non-small cell lung cancerC34Malignant neoplasm of bronchus and lungDRKS00029641Molekulare PneumologieUniversitätsklinikum Erlangen
招募中
不适用
POINTING: Towards patient-tailored cancer immunotherapy supported by a multifaceted predictive signature composed of integrative omics and molecular imaging.NSCLCskin cancer (melanoma)10027476NL-OMON51740niversitair Medisch Centrum Groningen200
已完成
2 期
Dendritic Cell Vaccine for the treatment of Stage IIIb Cervical Cancer patientsCTRI/2016/12/007530Department of Science and Technology DST54
Unknown
不适用
Feasibility 'innate' allogeneic stem cells transplantioHematological malignancies (hematologische maligniteiten)Allogeneic stem cells transplantation (allogene stamcel transplantatie)Innate immune system (aangeboren immuunsysteem)NL-OMON25484MC UtrechtHeidelberglaan 1003584 CX Utrecht35